---
layout: page
title: News
description: Lab's news
---

* (05/2022) Our paper "Risk and outcome of breakthrough COVID-19 infections in vaccinated patients with cancer: real-world evidence from the National COVID Cohort Collaborative" has been accepted by Journal of Clinical Oncology. Congratulations to the authors. [[paper]](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061155/)

* (04/2022) Our paper "Targeting DNA polymerase to DNA double-strand breaks reduces DNA deletion size and increases templated insertions generated by CRISPR/Cas9" has been accepted by Nucleic Acids Research. Conguatulations! [[paper]](https://academic.oup.com/nar/article/50/7/3944/6552087?login=false)

* (04/2022) Conguatulations! Our paper "HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion" has been accepted by Molecular Therapy. [[paper]](https://www.sciencedirect.com/science/article/abs/pii/S1525001622000922?casa_token=uYa8siR5sogAAAAA:IbdsxGPdqbBEvC9hn_AZVu3SYTvUXOb7w-086fVYCvzDN7yrNEirul4Du-toxF-GUfoQlUdDiQ)

* (03/2022) Our paper "Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients' Response to Anti–PD-1 Immune Checkpoint Blockade" has been accepted by Clinical Cancer Research. Congratulations to the authors. [[paper]](https://aacrjournals.org/clincancerres/article-abstract/28/6/1192/682031/Circulating-Immune-Bioenergetic-Metabolic-and)

* (03/2022) Conguatulations! Our paper "Uncovering the dynamic effects of DEX treatment on lung cancer by integrating bioinformatic inference and multiscale modeling of scRNA-seq and proteomics data" has been accepted. [[paper]](https://arxiv.org/abs/2203.00743)

* (02/2022) Conguatulations! Our paper "Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion" has been accepted by Nature nanotechnology. [[paper]](https://www.nature.com/articles/s41565-021-01032-w)

* (01/2022) Our paper "Uncovering the system vulnerability and criticality of human brain under evolving neuropathological events in Alzheimer’s Disease. " has been accepted. Congratulations to the authors. [[paper]](https://arxiv.org/abs/2201.08941)

* (01/2022) Our paper "Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. " has been accepted. Congratulations to the authors. [[paper]](https://www.nature.com/articles/s41565-021-01032-w)

* (01/2022) Our paper "Organoids in recapitulating tumorigenesis driven by risk factors: Current trends and future perspectives. " has been accepted by International Journal of Biological Sciences.. Congratulations to the authors. [[paper]](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066109/)

* (01/2022) Our paper "Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. " has been accepted. Congratulations to the authors. [[paper]](https://www.nature.com/articles/s41565-021-01032-w)

* (01/2022) Our paper "Single-Cell RNA-Seq Technologies and Computational Analysis Tools: Application in Cancer Research. " has been accepted. Congratulations to the authors. [[paper]](https://link.springer.com/protocol/10.1007/978-1-0716-1896-7_23)

* (01/2022) Our paper "Flap endonuclease 1 Facilitated Hepatocellular Carcinoma Progression by Enhancing USP7/MDM2-mediated P53 Inactivation." has been accepted by International journal of biological sciences. Congratulations to the authors. [[paper]](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771828/)

* (12/2021)Our paper "Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes" has been accepted by Frontiers in oncology. Congratulations to the authors. [[paper]](https://europepmc.org/article/pmc/pmc8692779)

* (12/2021)Our paper "DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination." has been accepted. Congratulations to the authors. [[paper]](https://link.springer.com/article/10.1186/s13578-021-00555-y)

* (12/2021)Our paper "Devimistat in Combination with Bendamustine Potently Inhibits Tumor Growth and Promotes CD8+ T Cell Tumor Infiltration in a Syngeneic Mouse Model of CD30+ T-Cell Lymphoma." has been accepted. Congratulations to the authors. [[paper]](https://www.sciencedirect.com/science/article/pii/S0006497121042166?casa_token=4cGQEVHkeJAAAAAA:QqjY2EEoIUUL27hFvxXxmSw4wYiZb3X9eZrCt0CJn08308QmldpWHHNU4aoytZ9113vMbE23sQ)

* (11/2021)Our paper "A Oncogenic chaperoning of Hsp90 in glioma with FGFR3-TACC3." has been accepted. Congratulations to the authors. [[paper]](https://academic.oup.com/neuro-oncology/article-abstract/23/Supplement_2/ii4/6366649)

* (11/2021)Our paper "Identification and validation of ubiquitin-specific proteases as a novel prognostic signature for hepatocellular carcinoma." has been accepted. Congratulations to the authors. [[paper]](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949004/)

* (09/2021)Our paper "Flexible Principal Component Analysis for Exponential Family Distributions." has been accepted. Congratulations to the authors. [[paper]](https://arxiv.org/abs/2108.06876)

* (09/2021)Our paper "DSTG: deconvoluting spatial transcriptomics data through graph-based artificial intelligence." has been accepted. Congratulations to the authors. [[paper]](https://academic.oup.com/bib/article/22/5/bbaa414/6105942?login=false)

* (08/2021)Our paper "Organoids: Current Implications and Pharmaceutical Applications in Liver Diseases." has been accepted. Congratulations to the authors. [[paper]](https://www.ingentaconnect.com/content/ben/cmp/2021/00000014/00000004/art00005)

* (06/2021)Our paper "scGCN is a graph convolutional networks algorithm for knowledge transfer in single cell omics." has been accepted by. Congratulations to the authors. [[paper]](https://www.nature.com/articles/s41467-021-24172-y)

* (06/2021)Our paper "Outcomes of COVID-19 in patients with cancer: report from the National COVID Cohort Collaborative (N3C)." has been accepted. Congratulations to the authors. [[paper]](https://www.ingentaconnect.com/content/wk/jco/2021/00000039/00000020/art00002)

* (05/2021)Conguatulations! Our paper "Outcomes of COVID-19 in cancer patients: Report from the National COVID Cohort Collaborative (N3C)." has been accepted by Molecular Therapy. [[paper]](https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.1500)

* (04/2021)Conguatulations! Our paper "Multi-omics analysis of brain metastasis outcomes following craniotomy." has been accepted by Frontiers in Oncology. [[paper]](https://www.frontiersin.org/articles/10.3389/fonc.2020.615472/full)

* (04/2021)Conguatulations! Our paper "scLM: automatic detection of consensus gene clusters across multiple single-cell datasets." has been accepted. [[paper]](https://www.sciencedirect.com/science/article/pii/S167202292030142X)

* (03/2021)Conguatulations! Our paper "Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer." has been accepted. [[paper]](https://www.liebertpub.com/doi/full/10.1089/dna.2020.5613?casa_token=CEkLV6Q0dJIAAAAA%3Arwu2enn5C5cLlg3OaFY5hUXrVqdDB3In9h_0W8yfqM8R_pxe9dnRmB599g2QhFVIPFrq6Xb9kRmeRQ)

* (03/2021)Conguatulations! Our paper "IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway." has been accepted. [[paper]](https://www.sciencedirect.com/science/article/pii/S0304383520306583?casa_token=ffGIdgW-vnQAAAAA:p1ZmxnH5y8GfQIjdARuxmVkY4tl8Bvn2aUeQo4BLIwHNEkU5ygqzxRzYtOS9HLYnuVWtb1Nulw)

* (02/2021)Conguatulations! Our paper "3D scaffold-free microlivers with drug metabolic function generated by lineage-reprogrammed hepatocytes from human fibroblasts. Biomaterials." has been accepted. [[paper]](https://www.sciencedirect.com/science/article/pii/S0142961221000193?casa_token=9AQJVbF81iAAAAAA:wzdMdkE_SCJcEURR7b6ME6k481mIZ6kWBuH33xvgP8B7Gb3NmZl9gKTMqp8uXOnMuXnQ5YtUTg)

* (02/2021)Conguatulations! Our paper "correspondence Reply to K. Takada et al." has been accepted. [[paper]](https://www.researchgate.net/profile/Qianqian-Song-3/publication/355161555_Reply_to_K_Takada_et_al/links/61defb91323a2268f99d7e47/Reply-to-K-Takada-et-al.pdf)

* (01/2021)Conguatulations! Our paper "The emerging roles of exosomes in the chemoresistance of hepatocellular carcinoma." has been accepted. [[paper]](https://www.ingentaconnect.com/content/ben/cmc/2021/00000028/00000001/art00008)

### INVITED PRESENTATIONS
* (2022) “Data-driven Informatics Research for Precision Oncology". The University of Alabama at Birmingham, Informatics Institute PowerTalk Seminar Series.

* (2021) “Real World Data to Empower Observational Research: an N3C and OMOP use case” Wake Forest Center for Biomedical Informatics Colloquium.

* (2020) “Statistical modeling and leveraging of single cell data” at the ICCABS2020.

* (2020) “Automatic detection of consensus gene clusters across multiple single-cell datasets” at the Mini-symposium of Director’s Excellence in Cancer Research Award for Trainees.

* (2020) “Single-cell analysis predicts immunotherapy response in melanoma” at the Annual Research Core Symposium, Wake Forest Baptist Medical Center.8

* (2020) “scLM: a bioinformatics tool designed for co-expression analysis using single cell omics data” at the Research Progress Report Meeting. Department of Cancer Biology, Wake Forest University.

* (2019) “Single-cell RNA-seq profiling and its biological applications” at the Lung Disease Orientated Team (DOT) meeting. Comprehensive Cancer Center, Wake Forest School of Medicine.

* (2019) “Single-cell Secondary Analysis” at the First Omics Workshop. Department of Cancer Biology, Wake Forest University.

* (2019) “Bioinformatics applications in single cell data” at the Research Progress Report Meeting. Department of Cancer Biology, Wake Forest University.
